BioSpace News Archive

Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today reported financial results for the second quarter ended June 30, 2019 and provided key business updates.

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the publication of a multicenter clinical study demonstrating the accuracy of its QIAstat-Dx syndromic testing solution for diagnosing the causes of acute gastroenteritis

DON Recovery Services (DRS) has chosen to implement the MedicsCloud Addiction Medicine Clinical and Financial Suite from Advanced Data Systems (ADS) for electronic health records (EHR), Patient Workflow Design, and Billing Technology.

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health, today reported financial results for its first quarter ended June 30, 2019 and provided an update on recent developments.

HealthWarehouse.com, Inc. (OTC: HEWA) announced today that its net sales for the second quarter ended June 30, 2019, increased to $3,960,265 compared to $3,850,692 for the second quarter of 2018

Dr. Jo Varshney, a multi-disciplinary and celebrated leader in veterinary and human health development, along with a team of world class scientists and engineers in machine learning and in silico simulation bring clarity to drug development through better science.

CEL-SCI Corporation (NYSE American: CVM) today reported financial results for the quarter ended June 30, 2019.

Huntington Hospital announced that local philanthropists, Terri and Jerry Kohl have made a gift of $7 million to support the expansion of its new Huntington Heart and Vascular Center.

Cardax, Inc. announced that it filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to a proposed follow-on public offering of up to $15 million of the Company’s common stock and warrants.

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) today announced its financial results for the first quarter ended June 30, 2019